A Pilot Randomized Controlled Trial of Brief Cognitive-Behavioral Therapy for Anxiety in Patients with Terminal Cancer
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Learning Objectives: After completing this course, the reader will be able to: Explain the current state of evidence-based treatment for anxiety in patients with cancer and the need for tailored intervention, especially for those with terminal cancer.Discuss and utilize methods for increasing access to psychosocial intervention for patients with cancer who suffer significant physical and psychological morbidity.Describe the effect of a brief cognitive-behavioral therapy intervention tailored to the needs of patients with terminal cancer and comorbid anxiety symptoms. CME This article is available for continuing medical education credit at CME.TheOncologist.com Introduction.: Patients with terminal cancer often experience marked anxiety that is associated with poor quality of life. Although cognitive-behavioral therapy (CBT) is an evidence-based treatment for anxiety disorders, the approach needs to be adapted to address realistic concerns related to having cancer, such as worries about disease progression, disability, and death. In this pilot randomized controlled trial (clinicaltrials.gov identifier NCT00706290), we examined the feasibility and potential efficacy of brief CBT to reduce anxiety in patients with terminal cancer. Methods.: We adapted CBT by developing treatment modules targeting skills for relaxation, coping with cancer worries, and activity pacing. Adults with incurable malignancies and elevated anxiety based on the Hamilton Anxiety Rating Scale (HAM-A) were randomly assigned to individual CBT or a waitlist control group. Primary outcomes included the number of completed CBT visits and the change in HAM-A scores from baseline to 8-week follow-up per a treatment-blind evaluator. The feasibility criterion was 75% adherence to the intervention. Results.: We randomized 40 patients with terminal cancers to CBT (n = 20) or waitlist control (n = 20) groups; 70% completed posttreatment assessments. Most patients who received CBT (80%) participated in at least five of the required six therapy sessions. Analysis of covariance models, adjusted for baseline scores, showed that those assigned to CBT had greater improvements in HAM-A scores compared to the control group, with an adjusted mean difference of –5.41 (95% confidence interval: –10.78 to –0.04) and a large effect size for the intervention (Cohen's d = 0.80). Conclusion.: Providing brief CBT tailored to the concerns of patients with terminal cancer was not only feasible but also led to significant improvements in anxiety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Psychosocial interventions have been found to be efficacious in reducing anxiety in adults with cancer, as well as having positive long-term effects on quality of life (Osborn et al., 2006; Greer et al, 2012; Jacobsen & Jim, 2008).”
From Utilizing a Manualized Therapy to Provide Parallel Treatment to Older Adults With Cancer and Their Caregivers: A Case Study (2022) · cites this paper as Greer et al, 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence suggests that CBT may benefit advanced-stage cancer patients by reducing anxiety symptoms, improving QL [33], and decreasing psychiatric disorders, which have been observed in cancer patients who were classified as high-risk for the development of such disorders [25].”
From A phase II study in advanced cancer patients to evaluate the early transition to palliative care (the PREPArE trial): protocol study for a randomized controlled trial. (2015) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020 · cited 1×
“Finally, to assess quality of life, we used the Functional Assessment of Cancer Therapy-General (FACT-G) Questionnaire [30], which has been administered in multiple medical settings to patients with diverse tumor types.”
MethodLenggenhager, J. (1947) · PubMed · Cited by 1,772
Hoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420 · cited 1×
“Although CBT is a well-established and efficacious treatment for anxiety disorders in the general population [19], the intervention usually targets unrealistic fears and maladaptive avoidance behaviors.”
BackgroundCancer Care for the Whole Patient: Meeting Psychosocial Health Needs
(2008) · National Academies Press eBooks · doi:10.17226/11993 · Cited by 708
Psychiatric morbidity and its recognition by doctors in patients with cancer
Fallowfield, L., Ratcliffe, D., Jenkins, V, & Saul, J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1724 · Cited by 694 · cited 1×
“Patients with poor-prognosis cancers are at heightened risk for psychiatric morbidity and suffer considerable disease burden that may limit their ability to engage in psychosocial services [31].”
BackgroundAnxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic
NOYES, R. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.8.1083 · Cited by 684
Newell, S. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.558 · Cited by 591
Hopwood, P., Stephens, R. J., & for the British Medical Research Council Lung Cancer Working Party (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.893 · Cited by 566
Screening for emotional distress in cancer patients: a systematic review of assessment instruments
Vodermaier, A., Linden, W., & Siu, C. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp336 · Cited by 541 · cited 1×
“Designed for medical patients, the HADS demonstrates adequate psychometric properties for use in samples of individuals with cancer [29].”
BackgroundCella, D., Hahn, E. A., & Dineen, K. (2002) · Quality of Life Research · doi:10.1023/a:1015276414526 · Cited by 523
Shear, M. K., Vander Bilt, J., Rucci, P., Endicott, J., Lydiard, B., Otto, M. W., Pollack, M. H., Chandler, L., Williams, J., Ali, A., et al. (2001) · Depression and Anxiety · doi:10.1002/da.1033 · Cited by 483
Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs: (718322007-001)
(2007) · PsycEXTRA Dataset · doi:10.1037/e718322007-001 · Cited by 423
Jacobsen, P. B., & Jim, H. S. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2008.0003 · Cited by 382
What is the evidence for the use of mindfulness‐based interventions in cancer care? A review
Shennan, C., Payne, S., & Fenlon, D. (2011) · Psycho-Oncology · doi:10.1002/pon.1819 · Cited by 271 · cited 1×
“Using mindfulness interventions to increase acceptance requires further study and may have particular benefit for patients diagnosed with cancer, not simply for alleviating anxiety [13] but also for buffering the expected declines in health-related quality of life.”
BackgroundDelgado-Guay, M., Parsons, H. A., Li, Z., Palmer, J. L., & Bruera, E. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0529-7 · Cited by 259
Lo, C., Zimmermann, C., Rydall, A., Walsh, A., Jones, J. M., Moore, M. J., Shepherd, F. A., Gagliese, L., & Rodin, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.9712 · Cited by 228 · cited 1×
“We believe the targeted approach we have employed to treat anxiety in patients with terminal cancer would require specification for alleviating depression, perhaps by addressing demoralization and hopelessness, which strongly correlate with mood symptoms in this population [35, 36].”
Management of distress in cancer patients.
Holland, J. C., & Alici, Y. (2010) · PubMed · Cited by 226
Mack, J. W., Block, S. D., Nilsson, M., Wright, A., Trice, E., Friedlander, R., Paulk, E., & Prigerson, H. G. (2009) · Cancer · doi:10.1002/cncr.24360 · Cited by 182
Self-citationMehnert, A., Vehling, S., Höcker, A., Lehmann, C., & Koch, U. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.02.013 · Cited by 171
Luckett, T., Butow, P. N., King, M. T., Oguchi, M., Heading, G. S., Hackl, N. A., Rankin, N. M., & Price, M. A. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0932-8 · Cited by 167
Burden to Others and the Terminally Ill
Chochinov, H. M., Kristjanson, L. J., Hack, T. F., Hassard, T. H., McClement, S., & Harlos, M. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.12.012 · Cited by 167
Greer, J. A., Pirl, W. F., Park, E. R., Lynch, T. J., & Temel, J. S. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.03.005 · Cited by 164
Self-citationDuHamel, K. N., Mosher, C. E., Winkel, G., Labay, L. E., Rini, C., Meschian, Y. M., Austin, J., Greene, P. B., Lawsin, C. R., Rusiewicz, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8722 · Cited by 151
Psychosocial interventions for patients with advanced cancer – a systematic review of the literature
Uitterhoeve, R. J., Vernooy, M., Litjens, M., Potting, K., Bensing, J., De Mulder, P., & van Achterberg, T. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602103 · Cited by 143
Moorey, S., Cort, E., Kapari, M., Monroe, B., Hansford, P., Mannix, K., Henderson, M., Fisher, L., & Hotopf, M. (2009) · Psychological Medicine · doi:10.1017/s0033291708004169 · Cited by 129
Anxiety disorders in advanced cancer patients: Correlates and predictors of end‐of‐life outcomes
Spencer, R., Nilsson, M., Wright, A., Pirl, W., & Prigerson, H. (2010) · Cancer · doi:10.1002/cncr.24954 · Cited by 124 · cited 1×
“Moreover, such symptoms may compromise medical treatment because anxiety is associated with challenges in the physician-patient relationship, chemotherapy dose delays and reductions, and more aggressive care at the end of life [4–7].”
BackgroundSelf-citationPrognostic acceptance and the well-being of patients receiving palliative care for cancer
Thompson, G. N., Chochinov, H. M., Wilson, K. G., McPherson, C. J., Chary, S., O'Shea, F. M., Kuhl, D. R., Fainsinger, R. L., Gagnon, P. R., & Macmillan, K. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9799 · Cited by 108
Burden and Benefit of Psychosocial Research at the End of Life
Pessin, H., Galietta, M., Nelson, C. J., Brescia, R., Rosenfeld, B., & Breitbart, W. (2008) · Journal of Palliative Medicine · doi:10.1089/jpm.2007.9923 · Cited by 101
Aggressiveness of care in a prospective cohort of patients with advanced NSCLC
Temel, J. S., McCannon, J., Greer, J. A., Jackson, V. A., Ostler, P., Pirl, W. F., Lynch, T. J., & Billings, J. A. (2008) · Cancer · doi:10.1002/cncr.23620 · Cited by 97
Self-citationTailoring cognitive-behavioral therapy to treat anxiety comorbid with advanced cancer
Greer, J. A., Park, E. R., Prigerson, H. G., & Safren, S. A. (2010) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.24.4.294 · Cited by 96
Self-citationAnxiety and its management in advanced cancer
Roth, A. J., & Massie, M. J. (2007) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0b013e32813aeb23 · Cited by 88
Shepherd, L., Goldstein, D., Whitford, H. S., Thewes, B., Brummell, V., & Hicks, M. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.05.018 · Cited by 86
Development and validation of a computer-administered version of the Hamilton Rating Scale.
Kobak, K. A., Reynolds, W. M., & Greist, J. H. (1993) · Psychological Assessment · doi:10.1037//1040-3590.5.4.487 · Cited by 75
Promoting evidence‐based psychosocial care for cancer patients
Jacobsen, P. B. (2009) · Psycho-Oncology · doi:10.1002/pon.1468 · Cited by 68 · cited 1×
“Many barriers exist in conducting research with patients who have terminal cancers in particular, such as the lack of appropriate measures to screen for anxiety and depression; limited dissemination of empirically supported therapies and practice guidelines; and concerns that disease burden and impaired functioning ma…”
Background
Cited by
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Riba, M. B., Donovan, K. A., Andersen, B., Braun, I., Breitbart, W. S., Brewer, B. W., Buchmann, L. O., Clark, M. M., Collins, M., Corbett, C., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0048 · Cited by 871
Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
Andersen, B. L., Lacchetti, C., Ashing, K., Berek, J. S., Berman, B. S., Bolte, S., Dizon, D. S., Given, B., Nekhlyudov, L., Pirl, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00293 · Cited by 318
Self-citationPsychosocial interventions for advanced cancer patients: a systematic review
Teo, I., Krishnan, A., & Lee, G. L. (2019) · Psycho-Oncology · doi:10.1002/pon.5103 · Cited by 205
Okuyama, T., Akechi, T., Mackenzie, L., & Furukawa, T. A. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.03.012 · Cited by 132
Greer, J. A., Jacobs, J., Pensak, N., MacDonald, J. J., Fuh, C.-X., Perez, G. K., Ward, A., Tallen, C., Muzikansky, A., Traeger, L., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0536 · Cited by 112
“In our prior, in-person CBT study with this population, 80% of participants adhered to the intervention, with 53% of sessions taking place on the same day as other medical appointments or via telephone, facilitating participation [13].”
BackgroundMethodSelf-citation
Metadata
- Authors
- Greer, J. A., Traeger, L., Bemis, H., Solis, J., Hendriksen, E. S., Park, E. R., Pirl, W. F., Temel, J. S., Prigerson, H. G., & Safren, S. A.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Greer, Joseph A.
- ORCID
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-11
- Volume
- 17
- Issue
- 10
- Pages
- 1337-1345
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- PMC
- PMC3481900
- OpenAlex
- W2171324372
- Cited by
- 111
- References
- 39
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 10 · 2023: 15 · 2022: 8 · 2021: 10 · 2020: 12 · 2019: 9 · 2018: 13 · 2017: 9 · 2016: 4 · 2015: 3 · 2014: 5
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Oncologist (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R03CA128478)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- terminal cancer, anxiety, cognitive behavioral therapy, brief psychotherapy, cancer-related anxiety, treatment feasibility, relaxation training, activity pacing, psychosocial interventions, quality of life, medication adherence
- MeSH terms
- Adult, Aged, Aged, 80 and over, Anxiety Disorders, Female, Humans, Male, Middle Aged, Neoplasms, Pilot Projects, Primary Health Care, Cognitive Behavioral Therapy, Treatment Outcome, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.